Attitudes and considerations of patients with ST-elevation myocardial infarction toward participation in randomized clinical trials by Polcwiartek, Christoffer et al.
 
  
 
Aalborg Universitet
Attitudes and considerations of patients with ST-elevation myocardial infarction
toward participation in randomized clinical trials
Polcwiartek, Christoffer; Behrndtz, Pia; Andersen, Ann Hass; Bregendahl, Marianne; Hald,
Helle Pedersen; Jensen, Svend Eggert
Published in:
American Heart Journal
DOI (link to publication from Publisher):
10.1016/j.ahj.2018.10.011
Creative Commons License
CC BY-NC-ND 4.0
Publication date:
2019
Document Version
Accepted author manuscript, peer reviewed version
Link to publication from Aalborg University
Citation for published version (APA):
Polcwiartek, C., Behrndtz, P., Andersen, A. H., Bregendahl, M., Hald, H. P., & Jensen, S. E. (2019). Attitudes
and considerations of patients with ST-elevation myocardial infarction toward participation in randomized clinical
trials. American Heart Journal, 208, 21-27. https://doi.org/10.1016/j.ahj.2018.10.011
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            ? Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            ? You may not further distribute the material or use it for any profit-making activity or commercial gain
            ? You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us at vbn@aub.aau.dk providing details, and we will remove access to
the work immediately and investigate your claim.
Accepted Manuscript
Attitudes and considerations of patients with ST-elevation
myocardial infarction towards participation in randomized clinical
trials
Christoffer Polcwiartek, Pia Behrndtz, Ann Hass Andersen,
Marianne Bregendahl, Helle Pedersen Hald, Svend Eggert Jensen
PII: S0002-8703(18)30307-7
DOI: https://doi.org/10.1016/j.ahj.2018.10.011
Reference: YMHJ 5799
To appear in: American Heart Journal
Received date: 23 April 2018
Accepted date: 20 October 2018
Please cite this article as: Christoffer Polcwiartek, Pia Behrndtz, Ann Hass Andersen,
Marianne Bregendahl, Helle Pedersen Hald, Svend Eggert Jensen , Attitudes and
considerations of patients with ST-elevation myocardial infarction towards participation in
randomized clinical trials. Ymhj (2018), https://doi.org/10.1016/j.ahj.2018.10.011
This is a PDF file of an unedited manuscript that has been accepted for publication. As
a service to our customers we are providing this early version of the manuscript. The
manuscript will undergo copyediting, typesetting, and review of the resulting proof before
it is published in its final form. Please note that during the production process errors may
be discovered which could affect the content, and all legal disclaimers that apply to the
journal pertain.
AC
C
EP
TE
D
 M
AN
U
SC
R
IP
T
1 
Attitudes and considerations of patients with ST-elevation myocardial 
infarction towards participation in randomized clinical trials 
 
Christoffer Polcwiartek, MD
a,b,c
*; Pia Behrndtz, RN, Diploma of Health
a
; Ann Hass Andersen, RN
a
; Mari-
anne Bregendahl, RN
a
; Helle Pedersen Hald, RN
a
; Svend Eggert Jensen, MD, PhD
a,c
 
 
a
 Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark 
b
 Unit of Epidemiology and Biostatistics, Aalborg University Hospital, Aalborg, Denmark 
c
 Department of Clinical Medicine, Aalborg University, Aalborg, Denmark 
 
Abbreviations: PCI, percutaneous coronary intervention; RCT, randomized clinical trial; STEMI, ST-
elevation myocardial infarction. 
 
* Reprint requests: Christoffer Polcwiartek, MD, Department of Cardiology, Aalborg University Hospital, 
Hobrovej 18–22, DK-9000 Aalborg, Denmark. 
E-mail address: c.polcwiartek@gmail.com (C. Polcwiartek). 
 
Manuscript contents: 2,573 (main text), 256 (abstract) words, 5 Fig., 26 refs.  
ACCEPTED MANUSCRIPT
AC
C
EP
TE
D
 M
AN
U
SC
R
IP
T
2 
Abstract 
Background: Limited evidence is available on attitudes and considerations of ST-elevation myocardial in-
farction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI) towards participa-
tion in randomized clinical trials (RCTs). Therefore, we investigated the ability of these patients to decide 
participation in RCTs. 
Methods: This was a questionnaire-based study. Over a 9-month period, we approached and invited 100 
consecutive STEMI patients who were asked to participate in at least one RCT during primary PCI. Patients 
were asked to fill out self-administered questionnaires concerning demographic data as well as attitudes and 
considerations towards participation in RCTs. 
Results: Patients had a mean age (SD) of 61 (12) years and most were males (82%). With a response rate of 
96%, a total of 94% accepted participation in at least one RCT. Most patients (78%) claimed to understand 
the information on participation in RCTs at an acceptable to satisfactory level, and 83% felt that they were 
given the possibility to ask additional questions during the decision-making process. Few patients (2%) 
claimed that they felt pressured to participate. The majority of patients (83%) stated that they participated to 
help clinical research, and 85% of patients would be willing to participate in future RCTs. It did not appear 
that the total number of RCTs in which patients participated in was of significant importance. 
Conclusions: Patients with STEMI undergoing primary PCI had positive attitudes and considerations to-
wards participation in RCTs despite their acute medical condition and the emergency environment. The 
overall self-assessed ability of patients to make a decision about participation in RCTs was good. 
 
Keywords: Attitudes; Considerations; Ethics; Patient participation; Percutaneous coronary intervention; 
Randomized controlled trial; ST-elevation myocardial infarction.  
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Introduction 
Randomized controlled trials (RCTs) remain the gold standard by which studies of treatment are assessed, 
and owing to several RCTs within the field of ST-elevation myocardial infarction (STEMI) research, the 
dominant reperfusion strategy has been deemed primary percutaneous coronary intervention (PCI), which 
has both improved survival and life quality of patients.(1) However, with demanding challenges in clinical 
practice such as improving access to care, door-to-balloon time, and adherence to guideline treatment rec-
ommendations, RCTs need to be even more sufficient in terms of developing novel treatments and improv-
ing existing ones for managing STEMI patients undergoing primary PCI.(2) As such, RCTs require efficient 
recruitment of adequately sized study populations being representative of contemporary clinical practice to 
be successful.(3) However, patient recruitment remains a widespread challenge across RCTs, and controver-
sy over especially informed consent in STEMI RCTs has existed for more than 30 years.(4) 
Although it is standard practice to ask STEMI patients to consent to participation in RCTs, this activity 
poses an ethical pitfall due to the acute medical condition of patients, the emergency environment, and the 
fact that randomization must occur within minutes of arrival at the catheterization laboratory.(4) Therefore, 
only limited time is remaining for oral and written information, and for patients to consider participation in 
RCTs. In addition, the psychological distress including fear of dying, ongoing pain, and helplessness associ-
ated with STEMI may compromise the decision-making process of patients and consequently the fundamen-
tals of securing informed consent.(5) Currently, few studies have assessed attitudes and considerations of 
patients towards participation in RCTs during the acute phase of STEMI and primary PCI, thus deeper in-
sight into this issue is warranted. Most of the focus in the literature has been on the experience of STEMI 
patients with the informed consent process in RCTs, although this may overlap with attitudes and considera-
tions of patients in some of the studies.(6-17) 
For these reasons, we investigated how STEMI patients undergoing primary PCI assessed their ability to 
decide participation in RCTs. We hypothesized that patients felt pressured to participate and had difficulty 
accepting participation if asked to enter more than one RCT.  
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Methods 
Study design and setting 
This was a questionnaire-based study conducted at the Department of Cardiology at Aalborg University 
Hospital, a tertiary referral hospital in the North Denmark Region, from March, 2012, to November, 2012. 
During this study period, our department had four running RCTs including DANAMI-3,(18) SORT OUT 
VI,(19) MITOCARE,(20) and GEVAMI,(21) in which participation could potentially be asked. 
 
Study population 
Our study population consisted of consecutive patients admitted with STEMI undergoing primary PCI who 
were asked to participate in at least one RCT. We only included patients ≥18 years of age who could read 
and understand Danish as these inclusion criteria were required by all RCTs. 
 
Recruitment and sample size estimate 
During the 9-month study period, trained research nurses (authors PB, AHA, MB, and HPH) approached 
patients. We asked 100 patients to participate in our study, which was needed to reach our sample size re-
quirement of at least 80 respondents. This sample size estimate was calculated using Raosoft® sample size 
calculator with a 95% confidence interval and a 5% error margin. 
 
Data collection 
Data were collected using a self-administered questionnaire. A pilot study of 10 patients was conducted to 
assess whether any questions required revision, and this was not necessary. 
Questionnaires were distributed to patients 6–48 hours following primary PCI. This ensured that patients 
were still in-hospital and had as well participation in RCTs as the provided information on RCTs present in 
memory. 
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The questionnaire was divided into two sections. Section 1 included age, sex, agreement for participation 
in RCTs, and the number of RCTs in which patients participated in. Section 2 assessed the following: level 
of understanding the actual RCT, level of opportunity to ask additional questions following the provided 
information, level of feeling pressured to participate, reasons for participation, and thoughts on future partic-
ipation. 
Some of the questions were closed-ended questions meaning that patients could only answer ‘Yes’, ‘No’, 
or ‘Do not know.’ Other questions were open-ended meaning that they could be answered on a scale ranging 
from 0–15 to give patients the opportunity of rating their experience. 
Patients were anonymized and given a unique ID number for registration purposes during data collection 
and analysis. 
 
Statistical analysis 
Continuous variables were reported as mean (SD), and categorical variables as counts (%). 
First, we stratified patients according to who accepted participation in RCTs, who did not accept partici-
pation, and who did not respond to the questionnaire. Between these groups, we tested for differences in age 
and sex as well as time, day, and month of admission with STEMI using independent t- and chi-squared 
tests, as appropriate. A p-value <0.05 was considered statistically significant. 
Second, we collapsed questions based on the 0–15 scale into two groups, with scores between 0–5 indi-
cating ‘unacceptable level’ and 6–15 indicating ‘acceptable to satisfactory level.’ 
Data management and analysis were performed using Stata, version 15.0 (StataCorp, College Station, 
Texas, USA) and R, version 3.5.1 (R Core Team (2018). R: A language and environment for statistical com-
puting. R Foundation for Statistical Computing, Vienna, Austria. URL: https://www.R-project.org/).  
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Ethics 
The North Denmark Region Committee on Health Research Ethics was approached, and our study did not 
require approval according to the Danish Law of Questionnaires and Interviews. As our study hold no per-
sonal data, registration by the Danish Data Protection Agency was not required. Our study conforms to prin-
ciples outlined by the Declaration of Helsinki,(22) thus our study was explained in written and oral format to 
patients. By Danish law, this type of questionnaire-based studies did not require informed consent of pa-
tients. 
 
Sources of funding 
No extramural funding was used to support this work. The authors are solely responsible for the design and 
conduct of this study, all study analyses, the drafting and editing of the paper and its final contents. 
 
Results 
Patients and characteristics 
Of all 100 consecutive STEMI patients undergoing primary PCI who were approached and asked to fill out 
the questionnaire in our study, 82 patients (82%) were males, and the remaining 18 patients (18%) were fe-
males. The mean (SD) age of patients was 61 (12) years. Most patients were asked to participate in RCTs 
during daytime hours and weekdays. 
 
Participation 
A total of 96 patients (out of 100) answered the questionnaire yielding a response rate of 96%. However, not 
all patients answered all questions resulting in varying response rates across individual questions. 
While 94 patients (out of 100) (94%) accepted inclusion in at least one RCT, 6 patients (out of 100) (6%) 
declined participation. Overall, between the 90 patients participating, 6 not participating, and 4 not respond-
ing to the questionnaire, no differences in age (p=0.481) and sex (p=0.399) as well as time (p=0.531), day 
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(p=0.738), and month (p=0.617) of admission with STEMI were observed. A consort diagram of all partici-
pating, non-participating, and non-responding patients including their baseline characteristics is depicted in 
Figure 1. In addition, the distribution of patients across individual RCTs is depicted in Figure 2. 
When comparing patients’ perception of number of RCTs in which they participated in with the actual 
registered number of RCTs, most patients believed they participated in less RCTs than was actually the case, 
as depicted in Figure 3. In addition, 20 patients (out of 100) (20%) claimed they did not know in which 
RCTs they participated in. 
 
Level of understanding 
Patients were asked to rate their level of understanding the information provided on participation in RCTs 
using the 0–15 scale, as depicted in Figure 4. A total of 88 patients (out of 96) answered the question, and 69 
patients (out of 88) (78%) claimed to understand the information at an acceptable to satisfactory level (score: 
6–15, mean score: 11). In comparison, 19 patients (out of 88) (22%) rated their level of understanding at an 
unacceptable level (score: 0–5, mean score: 2). 
Of the 6 patients declining participation in any RCT, 1 patient did not answer, 3 patients rated their un-
derstanding at an unacceptable level (score: 0–5), and the remaining 2 patients rated their understanding at an 
acceptable to satisfactory level (score: 6–15). 
 
Additional questions 
Patients were asked to rate their level of opportunity to ask additional questions about participation in RCTs 
using the 0–15 scale. A total of 84 patients (out of 96) answered the question, and 70 patients (out of 84) 
(83%) rated their experience at an acceptable to satisfactory level (score: 6–15), and 14 patients (out of 84) 
(17%) at an unacceptable level (score: 0–5).  
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Feeling pressured 
Patients were asked to rate their level of feeling pressured to participate in RCTs, and how this affected their 
decision-making process using the 0–15 scale. Overall, 2 patients (out of 96) (2%) claimed to have felt pres-
sured, of which 1 patient refrained from rating how this affected the decision-making process, and the re-
maining patient rated 8 meaning that this did not affect the decision. 
A total of 94 patients (out of 96) (98%) stated that they did not feel pressured to participate in RCTs. Of 
these, 55 patients chose to rate their level and rated their experience between 7–15, with the majority (n=51) 
rating higher than 11. 
 
Reasons for (non-)participation 
Patients were asked to state one or more motivational factors for participation in RCTs, as depicted in Figure 
5. The major reason for participation was ‘To help clinical research,’ which 75 patients (out of 90) (83%) 
marked. 
The 6 patients declining participation in RCTs marked the following: ‘Concerned about receiving an un-
tested treatment’ (n=1), ‘Do not wish to participate’ (n=1), ‘Unable to manage the decision’ (n=3), ‘Wish to 
discuss participation with relatives’ (n=1), ‘Previous experience with clinical research’ (n=1), ‘Felt pressured 
to participate’ (n=0), and ‘Do not know’ (n=2). 
 
Future participation 
Patients were asked if they felt positive about future participation in RCTs. A total of 93 patients (out of 100) 
marked: ‘Yes’ (n=79, 85%), ‘No’ (n=3, 3%), and ‘Do not know’ (n=11, 12%). Of these, the 6 patients de-
clining participation in RCTs marked: ‘Yes’ (n=4), ‘No’ (n=1), and ‘Do not know’ (n=1).  
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Discussion 
Our study revealed several valuable insights into attitudes and considerations of patients towards participa-
tion in RCTs during primary PCI for STEMI in Denmark. Our main finding was that 78% of patients showed 
an acceptable to satisfactory level of understanding the information provided on participation in RCTs, alt-
hough only half correctly stated the actual registered number of RCTs in which they participated in. Further, 
patients did not feel pressured to participate and had the opportunity to ask additional questions during the 
decision-making process. Notably, most patients participated to help clinical research and were positive 
about future participation in RCTs. 
To our knowledge, only limited evidence is available on attitudes and considerations of STEMI patients 
undergoing primary PCI towards participation in RCTs. Instead, most studies have focused on how STEMI 
patients understand the informed consent process in RCTs.(6-17) However, that selected Danish STEMI 
patients undergoing primary PCI in our study claimed they (a) had an acceptable to satisfactory level of un-
derstanding; (b) had the opportunity to ask additional questions; (c) did not feel pressured to participate; (d) 
wanted to help clinical research; and (e) were positive about future participation are all relevant findings 
underscoring the ethical justification of RCTs among STEMI patients.(4) These findings generally corrobo-
rates a recent international survey observing that out of 2,194 former clinical research participants nearly 
50% participated to help advance clinical research, 81% considered the informed consent form easy to un-
derstand, and most would participate again and would recommend participation to others.(23) Studies have 
further suggested that STEMI patients participating in RCTs compared with similar non-participating pa-
tients overall had the same outcomes meaning that it is safe for STEMI patients to consent to RCTs without 
jeopardizing survival.(24, 25) Taken together, this further speaks to enhancing patient recruitment in STEMI 
RCTs as under-participation remains a longstanding systemic challenge worldwide.(3) 
Significant determinants of understanding the information provided on participation in RCTs among 
STEMI patients have been found to be the absence of pain at inclusion, high educational level, and male 
sex.(13) Especially, pain and other symptoms experienced during STEMI have been found to explain why 
some patients consent to RCTs to rid themselves of pain and to receive treatment immediately.(4, 8, 10, 11, 
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16, 17) Our study revealed that the circumstances during primary PCI place high demands to physicians 
providing the information on RCTs, and how the specialized medical and nursing staff managing the patient 
during the emergency acts. As such, it remains crucial that patients understand and feel that participation in 
RCTs is completely voluntary. 
Given the psychological distress of patients during the acute phase of STEMI and primary PCI, it is a 
challenge for physicians to thoroughly inform patients about RCTs. According to Ågård et al., 86% of physi-
cians felt that STEMI patients were unable to understand all the information provided on participation in 
RCTs.(7) However, in our study of selected STEMI patients undergoing primary PCI in Denmark, most pa-
tients (78%) claimed to understand the information at an acceptable to satisfactory level. Taken together, this 
was interpreted as sufficient as patients simultaneously felt they had the opportunity to ask additional ques-
tions during the decision-making process. In previous studies, rates of understanding the information provid-
ed on RCTs to make a good decision have been reported to range from 52–88%.(6, 9, 10, 12-17) In contrast, 
the corresponding rate in non-emergency cardiovascular RCTs has been reported to be as high as 90%.(26) 
That only 2% of patients in our study claimed to have felt pressured to participate in RCTs during the 
acute phase of STEMI and primary PCI did not match our hypothesis, as we initially believed that most pa-
tients would feel obliged to participate. Accordingly, this is rather reflected by the fact that 83% of patients 
in our study participated to help clinical research, and 85% would be willing to participate in future RCTs. 
These response rates are generally comparable with those of previous studies.(9, 10, 12, 15, 16) In addition, 
as none of the patients commented on the number of RCTs in which they participated in, it did not appear 
that this was of significant importance to patients. 
Despite promising, our findings should be considered in the light of various limitations. The findings may 
have been different in other countries due to cultural and social differences. The varying response rates 
across individual questions may raise the possibility of selection bias, as it is likely that returned question-
naires were from patients with more extreme experiences, both favorable and otherwise, or those interested 
in clinical research. Our study was conducted among STEMI patients asked to be included in at least one 
RCT during primary PCI, and it is possible that the study staff screened only patients they felt would accept 
participation rather than all patients meeting RCT criteria. In addition, the findings may be different in stud-
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ies involving more chronic and stable patients who are usually outpatients and may consider participation in 
RCTs over days to weeks rather than minutes as STEMI patients have to. 
 
Conclusion 
Danish STEMI patients appeared to have positive attitudes and considerations towards participation in RCTs 
despite their acute medical condition and the emergency environment. The overall self-assessed ability of 
patients to make a decision about participation in RCTs was good, not influenced by pressure or misunder-
standing of information, and driven by the fact that patients wanted to help clinical research and would be 
willing to participate in future RCTs.  
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Figure legends 
 
Figure 1: Consort diagram of all participating, non-participating, and non-responding patients including 
their baseline characteristics. 
 
Figure 2: The distribution of patients across individual RCTs. 
 
Figure 3: Comparison of patients’ perception of number of RCTs in which they participated in with the ac-
tual registered number of RCTs. 
 
Figure 4: The rated level of understanding the information about participation in RCTs of patients using the 
0–15 scale. 
 
Figure 5: Motivational factors of patients towards participation in RCTs.  
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